Quell Therapeutics
Entry
2021
Hold
5yr
Status
Active
Who owns Quell Therapeutics?
Quell Therapeutics is a British Biotech company, currently owned by SV Health Managers since 2021 and Jeito Capital.
Hand-verified · updated 2026-05-13
Open JSON · CC-BYOwnership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
SV Health ManagersActive
2021 · present(5yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
Jeito CapitalActive
2021 · present(5yr) · Jeito I · 2021 · VC
More from Jeito I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Quell Therapeutics?
Quell Therapeutics is currently owned by SV Health Managers and Jeito Capital, through Jeito I, since 2021.
When did SV Health Managers and 1 other acquire Quell Therapeutics?
SV Health Managers and 1 other acquired Quell Therapeutics in 2021.
Who has owned Quell Therapeutics over time?
Quell Therapeutics has been through 2 private-equity ownership periods: SV Health Managers · via SV7 Impact Medicine Fund · since 2021; Jeito Capital · via Jeito I · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue